CTKB Cytek Biosciences
- 5.760
- +0.130+2.31%
- 5.760
- 0.0000.00%
Cytek Biosciences News
Cytek Biosciences(CTKB.US) Officer Sells US$117.4K in Common Stock
$Cytek Biosciences(CTKB.US)$ Officer Yan Ming sold 20,000 shares of common stock on Apr 19, 2024 at an average price of $5.87 for a total value of $117.4K.Source: Announcement What is statement of cha
Cytek Biosciences(CTKB.US) Officer Sells US$13,304 in Common Stock
$Cytek Biosciences(CTKB.US)$ Officer Yan Ming sold 1,900 shares of common stock on Apr 9, 2024 at an average price of $7 for a total value of $13,304.Source: Announcement What is statement of changes
Form 144 | Cytek Biosciences(CTKB.US) Officer Proposes to Sell 268K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 9, $Cytek Biosciences(CTKB.US)$ Officer MING YAN intends to sell 40,000 shares of its common stock on Apr 9, with a total market value of approximately $268K. MING YAN ha
Optimistic Outlook: Cytek Biosciences Poised for Growth With New CFO Appointment
Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing
Ming Yan, Director, CHIEF TECHNOLOGY OFFICER, around March 18, 2024, sold 40,000 shares in Cytek Biosciences (CTKB) for $269,600. Following the Form 4 filing with the SEC, Yan has control over a total
Insider Sell: Cytek Biosciences Inc's (CTKB) Chief Technology Officer Ming Yan Sells 40,000 Shares
Cytek Biosciences(CTKB.US) Officer Sells US$269.6K in Common Stocks
$Cytek Biosciences(CTKB.US)$ Officer Yan Ming sold 40,000 shares of Common Stocks on Mar 18, 19, 2024 at an average price of $6.74 for a total value of $269.6K.Source: Announcement What is statement o
Cytek Biosciences Announces CFO Transition and New Appointment
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance
Cytek Biosciences (CTKB) said Tuesday it has appointed William McCombe as chief financial officer, effective immediately, and reaffirmed its full-year 2024 guidance. McCombe succeeds Patrik Jeanmonod,
Cytek Biosciences Names William McCombe To Succeed Patrik Jeanmonod As CFO; Reaffirms 2024 Outlook
Cytek Biosciences Appoints CFO
Cytek Biosciences Names William McCombe Chief Financial Officer
By Colin Kellaher Cytek Biosciences has named William McCombe chief financial officer of the life-sciences technology company. Cytek on Tuesday said McCombe succeeds Patrik Jeanmonod, who had been c
Cytek Biosciences Backs FY24 Rev $203M-$213M >CTKB
Cytek Biosciences Backs FY24 Rev $203M-$213M >CTKB
Cytek Biosciences Sees Positive Net Income for FY24, Assuming No Change in Currency Exchange Rates >CTKB
Cytek Biosciences Sees Positive Net Income for FY24, Assuming No Change in Currency Exchange Rates >CTKB
Cytek Biosciences: McCombe Succeeds Patrik Jeanmonod, Who Was Named Head of Corporate Development Analytics >CTKB
Cytek Biosciences: McCombe Succeeds Patrik Jeanmonod, Who Was Named Head of Corporate Development Analytics >CTKB
Cytek Biosciences Names William McCombe Chief Financial Officer; Reaffirms 2024 Revenue Outlook Of $203M-$213M Vs $207.86M Est.
Experienced executive with extensive background as CFO for global corporations across dynamic sectorsCytek reaffirms 2024 outlookFREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences,
Cytek Biosciences Reaffirms 2024 Outlook >CTKB
Cytek Biosciences Reaffirms 2024 Outlook >CTKB
Cytek Biosciences Names William McCombe Chief Fincl Officer >CTKB
Cytek Biosciences Names William McCombe Chief Fincl Officer >CTKB
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China
Cytek Biosciences (CTKB) on late Thursday unveiled a new manufacturing facility for cell analysis systems in Wuxi, China. The 50,000-square-foot facility will also support the operations, research and
Express News | Cytek Biosciences Opens New 50,000-Square-Foot Facility In Wuxi, China
Analysis
Price Target
No Data
